**§4.88b Schedule of ratings-infectious diseases, immune disorders**

**and nutritional deficiencies.**

Rating

**6300** Cholera, Asiatic:

As active disease, and for 3 months convalescence 100

Thereafter rate residuals such as renal necrosis under the

appropriate system.

**6301** Visceral Leishmaniasis:

During treatment for active disease 100

Note: A 100 percent evaluation shall continue beyond the cessation of
treatment for active disease. Six months after discontinuance of such
treatment, the appropriate disability rating shall be determined by
mandatory VA examination. Any change in evaluation based upon that or
any subsequent examination shall be subject to the provisions of
§3.105(e) of this chapter. Rate residuals such as liver damage or
lymphadenopathy under the appropriate system.

**6302** Leprosy (Hansen's Disease):

As active disease 100

Note: A 100 percent evaluation shall continue beyond the date that an
examining physician has determined that this has become inactive. Six
months after the date of inactivity, the appropriate disability rating
shall be determined by mandatory VA examination. Any change in
evaluation based upon that or any subsequent examination shall be
subject to the provisions of §3.105(e) of this chapter. Rate residuals
such as skin lesions or peripheral neuropathy under the appropriate
system.

**6304** Malaria:

As active disease 100

Note: The diagnosis of malaria depends on the identification of the
malarial parasites in blood smears. If the veteran served in an endemic
area and presents signs and symptoms compatible with malaria, the
diagnosis may be based on clinical grounds alone. Relapses must be
confirmed by the presence of malarial parasites in blood smears

Thereafter rate residuals such as liver or spleen damage under the

appropriate system.

**6305** Lymphatic Filariasis:

As active disease 100

Thereafter rate residuals such as epididymitis or lymphangitis

under the appropriate system.

**6306** Bartonellosis:

As active disease, and for 3 months convalescence 100

Thereafter rate residuals such as skin lesions under the

appropriate system.

**6307** Plague:

As active disease 100

Thereafter rate residuals such as lymphadenopathy under the

appropriate system.

**6308** Relapsing Fever:

As active disease 100

Thereafter rate residuals such as liver or spleen damage or central

nervous system involvement under the appropriate system.

**6309** Rheumatic fever:

As active disease 100

Thereafter rate residuals such as heart damage under the

appropriate system.

**6310** Syphilis, and other treponemal infections:

Rate the complications of nervous system, vascular system, eyes or ears.

(See DC 7004, syphilitic heart disease, DC 8013, cerebrospinal syphilis,

DC 8014, meningovascular syphilis, DC 8015, tabes dorsalis, and

DC 9301, dementia associated with central nervous system syphilis).

**6311** Tuberculosis, miliary:

As active disease 100

Inactive: See §§4.88c and 4.89.

**6313** Avitaminosis:

Marked mental changes, moist dermatitis, inability to retain

adequate nourishment, exhaustion, and cachexia 100

With all of the symptoms listed below, plus mental symptoms and

impaired bodily vigor 60

With stomatitis, diarrhea, and symmetrical dermatitis 40

With stomatitis, or achlorhydria, or diarrhea 20

Confirmed diagnosis with nonspecific symptoms such as: decreased

appetite, weight loss, abdominal discomfort, weakness, inability

to concentrate and irritability 10

**6314** Beriberi:

As active disease:

With congestive heart failure, anasarca, or

Wernicke-Korsakoff syndrome 100

With cardiomegaly, or; with peripheral neuropathy with footdrop or

atrophy of thigh or calf muscles 60

With peripheral neuropathy with absent knee or ankle jerks and

loss of sensation, or; with symptoms such as weakness, fatigue,

anorexia, dizziness, heaviness and stiffness of legs, headache or

sleep disturbance 30

Thereafter rate residuals under the appropriate body system.

**6315** Pellagra:

Marked mental changes, moist dermatitis, inability to retain

adequate nourishment, exhaustion, and cachexia 100

With all of the symptoms listed below, plus mental symptoms and

impaired bodily vigor 60

With stomatitis, diarrhea, and symmetrical dermatitis 40

With stomatitis, or achlorhydria, or diarrhea 20

Confirmed diagnosis with nonspecific symptoms such as: decreased

appetite, weight loss, abdominal discomfort, weakness, inability

to concentrate and irritability 10

**6316** Brucellosis:

As active disease 100

Thereafter rate residuals such as liver or spleen damage or meningitis

under the appropriate system.

**6317** Typhus, scrub:

As active disease, and for 3 months convalescence 100

Thereafter rate residuals such as spleen damage or skin conditions

under the appropriate system.

**6318** Melioidosis:

As active disease 100

Thereafter rate residuals such as arthritis, lung lesions or meningitis

under the appropriate system.

**6319** Lyme Disease:

As active disease 100

Thereafter rate residuals such as arthritis under the appropriate system

**6320** Parasitic diseases otherwise not specified:

As active disease 100

Thereafter rate residuals such as spleen or liver damage under

the appropriate system.

**6350** Lupus erythematosus, systemic (disseminated):

Not to be combined with ratings under DC 7809

Acute, with frequent exacerbations, producing severe impairment

of health 100

Exacerbations lasting a week or more, 2 or 3 times per year 60

Exacerbations once or twice a year or symptomatic during the

past 2 years 10

Note: Evaluate this condition either by combining the evaluations for
residuals under the appropriate system, or by evaluating DC 6350,
whichever method results in a higher evaluation.

**6351** HIV-Related Illness:

AIDS with recurrent opportunistic infections or with secondary

diseases afflicting multiple body systems; HIV-related illness

with debility and progressive weight loss, without remission,

or few or brief remissions 100

Refractory constitutional symptoms, diarrhea, and pathological weight

loss, or; minimum rating following development of AIDS-related

opportunistic infection or neoplasm 60

Recurrent constitutional symptoms, intermittent diarrhea, and on

approved medication(s), or; minimum rating with T4 cell count less

than 200, or Hairy Cell Leukoplakia, or Oral Candidiasis 30

Following development of definite medical symptoms, T4 cell of 200 or

more and less than 500, and on approved medication(s), or; with

evidence of depression or memory loss with employment limitations 10

Asymptomatic, following initial diagnosis of HIV infection, with or

without lymphadenopathy or decreased T4 cell count 0

Note (1): The term "approved medication(s)" includes medications
prescribed as part of a research protocol at an accredited medical
institution.

Note (2): Psychiatric or central nervous system manifestations,
opportunistic infections, and neoplasms may be rated separately under
appropriate codes if higher overall evaluation results, but not in
combination with percentages otherwise assignable above.

**6354** Chronic Fatigue Syndrome (CFS):

Debilitating fatigue, cognitive impairments (such as inability to

concentrate, forgetfulness, confusion), or a combination of other

signs and symptoms:

Which are nearly constant and so severe as to restrict routine

daily activities almost completely and which may occasionally

preclude self-care 100

Which are nearly constant and restrict routine daily activities

to less than 50 percent of the pre-illness level, or; which

wax and wane, resulting in periods of incapacitation of at least

six weeks total duration per year 60

Which are nearly constant and restrict routine daily activities to

50 to 75 percent of the pre-illness level, or; which wax and wane,

resulting in periods of incapacitation of at least four but less

than six weeks total duration per year 40

Which are nearly constant and restrict routine daily activities by

less than 25 percent of the pre-illness level, or; which wax and

wane, resulting in periods of incapacitation of at least two but less

than four weeks total duration per year 20

Which wax and wane but result in periods of incapacitation of at

least one but less than two weeks total duration per year, or;

symptoms controlled by continuous medication 10

Note: For the purpose of evaluating this disability, the condition will
be considered incapacitating only while it requires bed rest and
treatment by a physician.

\[29 FR 6718, May 22, 1964, as amended at 41 FR 11300, Mar. 18, 1976; 43
FR 45361, Oct. 2, 1978; 54 FR 4281, Jan. 30, 1989; 54 FR 10482, Mar. 13,
1989; 57 FR 10136, Mar. 24, 1992; 59 FR 677, Jan. 6, 1994. Redesignated
and amended at 59 FR 60902, Nov. 29, 1994, and 60 FR 37012, July 19,
1995; 61 FR 39875, July 31, 1996\]

**Supplement *Highlights* references**: 11(1), 13(1), 17(1).

*Next Section is §4.88c*

Reserved